• Products
  • Suppliers
  • Sourcing Requests
  • capsule
  • Paracetamol
  • Dexamethasone
  • semaglutide
  • peptides
  • Metformin
  • Ritonavir
  • liraglutide
  • Yaan Times Biotech Co., Ltd
  • Changsha Staherb Natural Ingredients Co., Ltd.
  • PURELIFE BIOTECH CO.,LTD.
  • Biocompounds Pharmaceutical Inc.
  • Xi'an Kaixiang Photoelectric Technology Co., Ltd
  • Apollo Healthcare Resources (Singapore)
  • Shanghai UFU Laboratory Equipment Co.,Itd
  • GN Chemicals CO,Ltd.
Post Sourcing Request Exhibition
  • Noxopharm’s Veyonda prevents cytokine storm in Covid-19 trial pharmaceutical-technology
    April 26, 2021
    Australian company Noxopharm has reported interim data from its NOXCOVID trial, which showed that its drug candidate Veyonda provided protection against hyper-inflammation (cytokine storm) in moderate Covid-19 patients.
  • Noxopharm Files Septic Shock Treatment Patent for Veyonda® americanpharmaceuticalreview
    April 15, 2021
  • Noxopharm reports Covid-19 trial programme to commence in Europe pharmaceutical-business-review
    July 01, 2020

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service